May 29, 2020
Menlo Therapeutics Receives FDA Approval of ZILXI(TM) (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea
May 14, 2020
2020 Insights into the U.S. Rosacea Market: Profiles of Key Players Including Allergan, Galderma and Sol-Gel Technologies
Feb 18, 2020
Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea
Feb 06, 2020
Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology
Oct 17, 2019
Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Oct 10, 2019
Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
Oct 04, 2019
Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years
Oct 04, 2019
Klox Technologies Inc. Announces Completion of the Acquisition of FB Dermatology
Aug 05, 2019
Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Jun 25, 2019
BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea
Jun 20, 2019
American Acne And Rosacea Society (AARS) Uncovers Real Impact Of Acne On Young Professionals During Acne Awareness Month
Jun 17, 2019
Almirall Partners With AARS To Raise Awareness About The Burden Of Disease And Importance Of Education For Dermatology Professionals For National Acne Awareness Month
May 22, 2019
BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea
Apr 15, 2019
#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma's Empowering Rosacea Awareness Month Social Media Campaign
Mar 29, 2019
Micreos Raises EUR30 Million for Endolysin Technology Set to Replace Antibiotics
Mar 04, 2019
BioPharmX Completes Enrollment in Phase 2b Trial of BPX-04 for Patients with Papulopustular Rosacea
Dec 05, 2018
The Most Common Signs of Rosacea by Pulse Light Clinic London
Dec 05, 2018
Rosacea Therapeutics Demand to Exceed US$ 2 Billion in 2019 - Persistence Market Research
Oct 29, 2018
Global Rosacea Market and Competitive Landscape 2014-2018 & 2023: Symptoms, Etiology, Diagnosis & Treatment Options
Oct 11, 2018
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea